文献速递类风湿关节炎

加拿大老龄化纵向研究中自然绝经年龄与绝经后女性类风湿关节炎关联的队列研究

A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging.
PubMed 文献 · Semin Arthritis Rheum · 2025-05-02

研究纳入加拿大老龄化纵向研究中45-85岁自然绝经且绝经前无类风湿关节炎的女性,随访10年,按自然绝经年龄≤44岁(参照)、45-49岁、≥50岁分组,采用Cox回归分析。调整多变量模型显示,自然绝经年龄≥50岁且激素替代治疗≥8年的女性较自然绝经年龄≤44岁且从未使用激素替代治疗者类风湿关节炎风险显著降低,HR 0.2(95%CI 0.1-0.7)。

要点

  • 自然绝经年龄≥50岁且激素替代治疗≥8年者较≤44岁且从未使用者类风湿关节炎风险降低,HR 0.2(95%CI 0.1-0.7)。
  • 研究提示较长雌激素暴露可能对类风湿关节炎发生风险有益。
  • 既往关于自然绝经年龄与类风湿关节炎的研究结果存在矛盾。

核心结论

  • 研究提示较长雌激素暴露可能对类风湿关节炎发生风险具有潜在有益作用。

研究设计与样本

  • 研究为来自加拿大老龄化纵向研究的队列研究,纳入45-85岁女性,随访10年。
  • 分析限于自然绝经且绝经前无类风湿关节炎的女性,自然绝经年龄分为≤44岁(参照)、45-49岁和≥50岁三组。
  • 采用生存分析确定类风湿关节炎发病时间,并使用未调整和调整多变量Cox回归模型分析关联。

主要发现

  • 调整多变量Cox回归模型显示,自然绝经年龄≥50岁且激素替代治疗≥8年的女性较自然绝经年龄≤44岁且从未使用激素替代治疗者类风湿关节炎风险显著降低,HR 0.2(95%CI 0.1-0.7)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Menopause represents a significant phase in a woman's life, marked by profound physiological changes. An early onset of menopause has been associated with a variety of negative outcomes. Estrogen has been shown to be protective of bone and joint health. Hormonal links to rheumatoid arthritis have been found; previous studies exploring age at natural menopause (ANM) and Rheumatoid arthritis have produced conflicting results. This study investigated the association between ANM and incidence of rheumatoid arthritis among postmenopausal Canadian women. The study included women between the ages of 45-85 years from the Canadian Longitudinal Study on Aging followed over a 10-year period. Analysis was restricted to naturally postmenopausal women that did not have rheumatoid arthritis prior to menopause. ANM was examined using the following categories ≤ 44 (reference), 45-49, and ≥50. Survival analysis was used to determine time to onset of rheumatoid arthritis. Unadjusted and adjusted multivariable Cox regression models were used to examine the relationship between ANM and incidence of rheumatoid arthritis. The adjusted multivariable Cox regression model showed significantly lower risk of rheumatoid arthritis in women with an older ANM of ≥50 years and who have been on hormone replacement therapy for ≥8 years with a hazard ratio of 0.2 (95 % CI: 0.1-0.7) compared to women with an ANM ≤ 44 who have never used hormone replacement therapy. Our findings suggest a potential beneficial effect of longer estrogen exposure on the risk of developing rheumatoid arthritis.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Kesibi D, Rotondi M, Edgell H, et al. A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging. Semin Arthritis Rheum. 2025. PMID: 40344934. doi:10.1016/j.semarthrit.2025.152747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。